BIOA

Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 01.45 M2.41 M2.05 M3.08 M 8.99 M Gross profit 01.45 M2.41 M2.05 M3.08 M 8.99 M Operating expenses 25.36 M17.9 M27.18 M25.19 M31.5 M 101.78 M Selling/general/admin expenses 6.14 M6.79 M7.34 M6.68 M7 M 27.81 M Research & development 19.23 M11.11 M19.84 M18.51 M24.5 M 73.97 M Operating income -25.36 M-16.45 M-24.77 M-23.14 M-28.42 M -92.78 M Non-Operating Income, Total 4.23 M3.52 M3.21 M2.97 M2.48 M 12.18 M Interest expense, net of interest capitalized 319 K255 K201 K149 K92 K 697 K Non-Operating Income, excl. Interest Expenses 3.91 M3.26 M3.01 M2.82 M2.39 M 11.48 M Unusual income/expense ————— — Pretax income -71.11 M-13.18 M-21.76 M-20.32 M-80.61 M -135.87 M Equity in earnings ————— — Taxes -151 K———-4 000 — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -21.13 M-12.93 M-21.56 M-20.17 M-25.94 M -80.61 M Discontinued operations ————— — Net income -21.13 M-12.93 M-21.56 M-20.17 M-25.94 M -80.61 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -21.13 M-12.93 M-21.56 M-20.17 M-25.94 M -80.61 M Basic earnings per share (Basic EPS) 15.77-0.36-0.6-0.56-0.72 -2.24 Diluted earnings per share (Diluted EPS) 15.77-0.36-0.6-0.56-0.72 -2.24 Average basic shares outstanding 10.73 M35.85 M35.85 M35.85 M35.93 M 143.48 M Diluted shares outstanding 10.73 M35.85 M35.85 M35.85 M35.93 M 143.48 M EBITDA -25.32 M-16.41 M-24.71 M-23.09 M-28.35 M -92.57 M EBIT -25.36 M-16.45 M-24.77 M-23.14 M-28.42 M -92.78 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 47 K37 K58 K49 K69 K 213 K